Journal of neuroimmunology
Journal
Overview
publication venue for
-
COVID-19, HHV6 and MOG antibody: A perfect storm.
2021
-
Synergistic effects of alcohol and HIV TAT protein on macrophage migration and neurotoxicity..
368.
2022
-
Characterization, isolation, and in vitro culture of leptomeningeal fibroblasts..
361.
2021
-
Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis..
309.
2017
-
Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women..
303.
2016
-
Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais..
288.
2015
-
The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease..
283.
2015
-
Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance..
276.
2014
-
Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits..
255.
2012
-
A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease..
254.
2012
-
Selected human leukocyte antigen class II polymorphisms and risk of adult glioma..
233.
2010
-
Gene expression profiling in nerve biopsy of vasculitic neuropathy..
225.
2010
-
NF-kappaB1 contributes to T cell-mediated control of Toxoplasma gondii in the CNS..
222.
2010
-
TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects..
216.
2009
-
Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex..
217.
2009
-
Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment..
210.
2009
-
Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine..
203.
2008
-
Transglutaminase-independent binding of gliadin to intestinal brush border membrane and GM1 ganglioside..
177.
2006
-
Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis..
171.
2005
-
CD40L deletion delays neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism..
164.
2005
-
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis..
164.
2005
-
Gene expression profiling in chronic inflammatory demyelinating polyneuropathy..
159.
2004
-
Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue..
159.
2004
-
The autoimmune T and B cell repertoires in monozygotic twins discordant for myasthenia gravis..
148.
2004
-
Coronavirus-induced demyelination occurs in the absence of CD28 costimulatory signals..
146.
2004
-
Induction of human IgM and IgG anti-GM1 antibodies in transgenic mice in response to lipopolysaccharides from Campylobacter jejuni..
146.
2004
-
Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis..
144.
2003
-
Serum anti-Fas antibody levels in amyotrophic lateral sclerosis..
142.
2003
-
Ganglioside reactive antibodies in the neuropathy associated with celiac disease..
127.
2002
-
Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression..
110.
2000
-
CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis..
109.
2000
-
Antibodies to chondroitin sulfates A, B, and C: clinico-pathological correlates in neurological diseases..
108.
2000
-
Experimental allergic neuritis in the SJL/J mouse: induction of severe and reproducible disease with bovine peripheral nerve myelin and pertussis toxin with or without interleukin-12..
107.
2000
-
Antigen presenting capacity of brain microvasculature in altered peptide ligand modulation of experimental allergic encephalomyelitis..
93.
1999
-
Involvement of capsaicin sensitive primary afferents in thymulin-induced hyperalgesia..
91.
1998
-
Antibodies to chondroitin sulfate C: a new detection assay and correlations with neurological diseases..
84.
1998
-
Altered peptide ligand modulation of experimental allergic encephalomyelitis: immune responses within the CNS..
81.
1998
-
Immunization of guinea pigs with human choline acetyltransferase induces selective lower motoneuron destruction..
78.
1997
-
Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides..
78.
1997
-
Experimental immune-mediated damage of septal cholinergic neurons..
77.
1997
-
The effect of thymectomy on autoreactive T- and B-lymphocytes in myasthenia gravis..
74.
1997
-
Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis..
58.
1995
-
IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses..
58.
1995
-
Experimental autoimmune nigral damage in guinea pigs..
57.
1995
-
Affinity studies of human anti-MAG antibodies in neuropathy..
52.
1994
-
Somatically mutated member of the human V lambda VIII gene family encodes anti-myelin-associated glycoprotein (MAG) activity..
51.
1994
-
Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells..
50.
1994
-
Dopamine receptors on human T- and B-lymphocytes..
45.
1993
-
Human muscle acetylcholine receptor reactive T and B lymphocytes in the peripheral blood of patients with myasthenia gravis..
42.
1993
-
Vimentin-crossreactive antibodies induce cell death in primary cultures of embryonic spinal cord..
42.
1993
-
DNA sequence analysis and comparison of the variable heavy and light chain regions of two IgM, monoclonal, anti-myelin associated glycoprotein antibodies..
36.
1992
-
Cyclophosphamide alters the clinical and pathological expression of experimental autoimmune gray matter disease..
34.
1991
-
Identification of glycoconjugates which are targets for anti-Gal(beta 1-3)GalNAc autoantibodies in spinal motor neurons..
34.
1991
-
Malignant glioma modulation of immune function: relative contribution of different soluble factors..
33.
1991
-
The B-cells that express anti-MAG antibodies in neuropathy and non-malignant IgM monoclonal gammopathy belong to the CD5 subpopulation..
31.
1991
-
Molecular cloning of a human immunoglobulin heavy chain variable (vh) region with anti-myelin-associated glycoprotein activity..
30.
1990
-
Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: experimental autoimmune gray matter disease..
27.
1990
-
Autoantigens in human neuroblastoma cells..
26.
1990
-
Molecular cloning of a human immunoglobulin heavy chain variable (VH) region with anti-myelin-associated glycoprotein activity..
26.
1990
-
Monoclonal IgMs with anti-Gal(beta 1-3) GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins..
23.
1989
-
Induction of MHC class I antigens on glial cells is dependent on persistent mouse hepatitis virus infection..
22.
1989
-
Specificity of human anti-neurofilament autoantibodies..
21.
1989
-
Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron disease..
21.
1989
-
Monoclonal IgM in two patients with motor neuron disease bind to the carbohydrate antigens Gal(beta 1-3)GalNAc and Gal(beta 1-3)GlcNAc..
19.
1988
-
Immune reactive C3d on the surface of myelin sheaths in neuropathy..
18.
1988
-
Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes..
18.
1988
-
Antibodies to sulfated glucuronic acid containing glycosphingolipids in neuropathy associated with anti-MAG antibodies and in normal subjects..
17.
1988
-
Characterization of oligosaccharides that bind to human anti-MAG antibodies and to the mouse monoclonal antibody HNK-1..
12.
1986
-
Glycosaminoglycan antigens in peripheral nerve. Studies with antibodies from a patient with neuropathy and monoclonal gammopathy..
12.
1986
-
Correspondence: Electroconvulsive therapy in N-methyl-D-aspartate receptor encephalitis.
2024
-
Exploring the role of inflammation in the malignant transformation of low-grade gliomas.
2016
-
Immune surveillance of the central nervous system in multiple sclerosis--relevance for therapy and experimental models.
2014
-
Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities.
2021
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)